QT Imaging Holdings, Inc. (QTI)
Nasdaq · Healthcare · Medical Devices
$2.61−2.25%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $38.2M
- 52-week range
- $2.42 – $36.75
- 52-week change
- −92.55%
- EPS (trailing)
- −$1.40
- Analyst rating
- 1.0 Strong buy
- Next earnings
- Nov 10, 2026
Fiscal year to Dec 2025
- Revenue
- $18.9M (+287.89%)
- Net income
- −$21.1M
- Operating margin
- −23.4%
- Diluted EPS
- −$2.01
- Free cash flow
- −$9.1M
From the company’s annual report on SEC EDGAR.
About QT Imaging Holdings, Inc.
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. It serves patients, medical professionals, and radiologists. The company has a collaboration with Olea Medical S.A.S for the development of QTI Imaging-Olea Viewer; and a strategic partnership with Intelerad Medical Systems Incorporated. QT Imaging Holdings, Inc. was founded in 2012 and is headquartered in Novato, California.
Headquarters: Novato, United States · 31 employees · qtimaging.com